Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2022
DOI: 10.1016/j.micpath.2022.105403
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic activity and immunomodulatory potential of levofloxacin and Synoeca‐MP peptide against multi-resistant strains of Klebsiella pneumoniae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 43 publications
0
5
0
Order By: Relevance
“…These are cyclic Pps, classified according to the number of disulfide bridges made between the six cysteine residues preserved during evolution (α-and β-defensin and the macrocyclic structure θ-defensin). As with cathelicidins, defensins are also synthesized as inactive precursors, requiring proteolytic cleavage for activation [26].…”
Section: General Properties / Characteristics Of Antimicrobial Peptidesmentioning
confidence: 99%
“…These are cyclic Pps, classified according to the number of disulfide bridges made between the six cysteine residues preserved during evolution (α-and β-defensin and the macrocyclic structure θ-defensin). As with cathelicidins, defensins are also synthesized as inactive precursors, requiring proteolytic cleavage for activation [26].…”
Section: General Properties / Characteristics Of Antimicrobial Peptidesmentioning
confidence: 99%
“…Furthermore, AMPs can affect the maintenance of the integrity of the intestinal barrier by stimulating mucus synthesis and promoting the production of tight junction proteins and the repair of the endothelium ( 9 , 10 ). Interestingly, accumulating evidence shows the synergistic effects between AMPs or between AMPs and antibiotics, and these combinations can significantly reduce bacterial resistance ( 11 13 ). Owing to these favorable characteristics with infrequent drug resistance, broad-spectrum antimicrobial activities, rapid killing effects, and high capacity for synergies, AMPs have been considered attractive candidates for alternative antibiotics.…”
Section: Introductionmentioning
confidence: 99%
“…[ 18 ] Synoeca‐MP has already been tested in synergy with other drugs such as chlorhexidine and levofloxacin, which increased its activity against Pseudomonas aeruginosa and Klebsiella pneumoniae , respectively. [ 19,20 ] Regarding immune cytokines, synoeca‐MP has been shown to stimulate the production of pro‐inflammatory cytokines, such as TNF‐α and nitric oxide. [ 20 ] Due to its low hemolytic and cytotoxic activities, several biotechnological applications have been used to obtain efficient and cost‐effective approaches for the recombinant production and purification of this peptide.…”
Section: Introductionmentioning
confidence: 99%
“…[ 19,20 ] Regarding immune cytokines, synoeca‐MP has been shown to stimulate the production of pro‐inflammatory cytokines, such as TNF‐α and nitric oxide. [ 20 ] Due to its low hemolytic and cytotoxic activities, several biotechnological applications have been used to obtain efficient and cost‐effective approaches for the recombinant production and purification of this peptide. [ 21 ]…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation